Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Performance Evaluation Of Texture Analysis Based On Kinetic Parametric Maps From Breast DCE‐MRI In Classifying Benign From Malignant Lesions

Zejun Jiang, Jiandong Yin
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
To investigate the performance of texture analysis based on enhancement kinetic parametric maps derived from breast dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) in discriminating benign from malignant tumors.
This paper references
10.1016/j.clbc.2017.11.004
Diagnostic Performance of Mammographic Texture Analysis in the Differential Diagnosis of Benign and Malignant Breast Tumors
Zhiming Li (2018)
10.1016/j.acra.2008.06.005
Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI.
K. Nie (2008)
10.2214/AJR.15.15957
Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.
H. Abe (2016)
10.1016/j.critrevonc.2014.03.002
Personalized medicine: present and future of breast cancer management.
R. Sabatier (2014)
10.1109/TSMC.1973.4309314
Textural Features for Image Classification
R. Haralick (1973)
10.1016/j.ejrad.2017.06.019
Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Ming Fan (2017)
10.1007/s00330-006-0348-5
Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography
E. Hauth (2006)
10.1002/jmri.26556
Role of texture analysis in breast MRI as a cancer biomarker: A review
Rhea D Chitalia (2019)
10.24920/003516
Value of Magnetic Resonance Imaging Texture Analysis in the Differential Diagnosis of Benign and Malignant Breast Tumors.
Bo-Tao Wang (2019)
10.1007/978-1-4614-5647-6_1
Breast cancer statistics
J. Ma (2000)
10.1158/1078-0432.CCR-14-0990
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
J. O'Connor (2014)
EANM procedure guidelines for tumour PET imaging: version 1.0
R Boellaard (2010)
10.1002/mrm.10496
Textural analysis of contrast‐enhanced MR images of the breast
P. Gibbs (2003)
10.1016/J.ACRA.2005.08.035
A Fuzzy C-Means (FCM)-Based Approach for Computerized Segmentation of Breast Lesions in Dynamic Contrast-Enhanced MR Images1
W. Chen (2006)
10.1016/J.CRAD.2004.07.008
Texture analysis of medical images.
G. Castellano (2004)
Breast cancer : epidemiology and etiology Breast cancer statistics , 2013
PL Bedard
10.1007/s00330-008-0863-7
Breast MRI: guidelines from the European Society of Breast Imaging
R. Mann (2008)
10.1007/s12194-019-00543-5
A method for the automated classification of benign and malignant masses on digital breast tomosynthesis images using machine learning and radiomic features
A. Sakai (2019)
10.5405/jmbe.1183
Classification of Small Lesions in Breast MRI: Evaluating The Role of Dynamically Extracted Texture Features Through Feature Selection.
Mahesh B. Nagarajan (2013)
10.1259/bjr.20140369
The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.
S. Alobaidli (2014)
10.1186/s13046-015-0140-y
Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI
Jiandong Yin (2015)
10.1097/00004728-199907000-00024
Heterogeneity analysis of Gd-DTPA uptake: improvement in breast lesion differentiation.
B. Issa (1999)
10.1016/j.patcog.2015.03.009
Performance evaluation of classification algorithms by k-fold and leave-one-out cross validation
T. Wong (2015)
10.1007/s12013-014-0459-6
Breast Cancer: Epidemiology and Etiology
Ziqi Tao (2014)
10.1097/RLI.0000000000000222
Pretreatment Prognostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, and Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients
M. Pickles (2016)
Statistical and Structural Approaches to Texture
M.
10.1007/s00330-019-06392-5
Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI
N. Onishi (2019)
10.1186/s12880-017-0239-z
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
Kirsi Holli-Helenius (2017)
10.1007/PL00006909
Contrast-enhanced breast MRI: factors affecting sensitivity and specificity
C. Piccoli (1997)
How to cite this article: Jiang Z, Yin J. Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions
J W Fletcher (2008)
10.1002/JMRI.1880070613
Multifeature analysis of Gd‐enhanced MR images of breast lesions
S. Sinha (1997)
10.1102/1470-7330.2013.0015
Quantifying tumour heterogeneity with CT
B. Ganeshan (2013)
10.1016/j.breast.2019.10.018
Overview of radiomics in breast cancer diagnosis and prognostication
A. Tagliafico (2019)
10.1148/radiol.2015151169
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
10.1259/bjr/50743919
Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis.
A. Karahaliou (2010)
10.1007/s00330-006-0505-x
Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer
F. Montemurro (2006)
10.1118/1.4921996
Parenchymal texture analysis in digital mammography: A fully automated pipeline for breast cancer risk assessment.
Y. Zheng (2015)
10.1002/jmri.10140
Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging
Y. Guo (2002)
10.1007/s00259-009-1297-4
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
R. Boellaard (2009)
10.1002/jmri.25921
DCE‐MRI texture analysis with tumor subregion partitioning for predicting Ki‐67 status of estrogen receptor‐positive breast cancers
Ming Fan (2018)
10.1148/radiol.2015150013
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.
N. Hylton (2016)
10.3322/caac.21203
Breast cancer statistics, 2013
C. Desantis (2014)
10.1007/s00330-017-5014-6
Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study
Catharina S Lisson (2017)
Texture analysis on 18 F‐FDG PET/CT images to differentiate malignant and benign bone and soft‐tissue lesions
R Xu (2014)
10.1201/9781420037593.ch19
Machine vision
R. Jain (1995)
10.1007/978-0-387-39940-9_540
Principal Component Analysis
H. Shen (2009)
10.1016/S1361-8415(96)80007-7
Deformable models in medical image analysis: a survey
T. McInerney (1996)
10.1002/(SICI)1522-2586(199912)10:6<945::AID-JMRI6>3.0.CO;2-I
Dynamic contrast‐enhanced MRI in the differentiation of breast tumors: User‐defined versus semi‐automated region‐of‐interest analysis
G. Liney (1999)
10.1109/42.796284
Nonrigid registration using free-form deformations: application to breast MR images
D. Rueckert (1999)
10.1016/j.mri.2016.03.001
Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
R. Chang (2016)
10.1002/mrm.21347
Volumetric texture analysis of breast lesions on contrast‐enhanced magnetic resonance images
W. Chen (2007)
10.3892/ol.2018.9196
Texture features and pharmacokinetic parameters in differentiating benign and malignant breast lesions by dynamic contrast enhanced magnetic resonance imaging.
Qingliang Niu (2018)
10.1016/j.mri.2014.08.034
Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
J. Kim (2015)
10.1038/nrclinonc.2011.19
Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?
P. Bedard (2011)
10.3348/kjr.2018.0587
Kinetic Features of Invasive Breast Cancers on Computer-Aided Diagnosis Using 3T MRI Data: Correlation with Clinical and Pathologic Prognostic Factors
S. Song (2019)
10.1016/j.mri.2013.07.002
Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
R. Abramson (2013)
10.2967/jnumed.107.047787
Recommendations on the Use of 18F-FDG PET in Oncology
J. Fletcher (2008)
10.1118/1.2760460
SU‐FF‐I‐83: Effect of Tumor Motion On the Pixel‐Based Analysis of DCE‐MRI Data for Cervical Cancer
Jiankui Yuan (2007)
10.1177/0284185117705010
Agreement between MRI and pathologic analyses for determination of tumor size and correlation with immunohistochemical factors of invasive breast carcinoma
E. Y. Yoo (2018)
A fuzzy c-means (FCM)-based approach for computerized segmentation of breast lesions in dynamic contrast-enhanced MR images.
W. Chen (2006)
10.1186/s40644-019-0233-5
Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling
A. C. Yeh (2019)
10.1002/mrm.26029
Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR
Z. Li (2016)
10.1016/j.acra.2019.05.001
Kinetic Analysis of Lesions Identified on a Rapid Abridged Multiphase (RAMP) Breast MRI Protocol.
Sadia Choudhery (2019)
10.1016/j.ijrobp.2016.03.018
Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
J. Wu (2016)
Predictive ability of DWI/ADC and DCE-MRI kinetic parameters in differentiating benign from malignant breast lesions and in building a prediction model.
Atiya Allarakha (2019)
A fuzzy C‐means (FCM)‐based approach for computerized segmentation of breast lesions in dynamic contrast‐ enhanced
W Chen (2006)
10.1007/s11060-018-2984-4
Diagnostic accuracy of MRI texture analysis for grading gliomas
Austin Ditmer (2018)
10.1002/jmri.26732
Characterization of Sub‐1 cm Breast Lesions Using Radiomics Analysis
P. Gibbs (2019)
10.1148/radiol.13122697
Quantitative imaging in cancer evolution and ecology.
R. Gatenby (2013)
10.1148/radiol.2015150358
Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.
Y. Cui (2016)
10.1158/1078-0432.CCR-07-0238
Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
A. Jackson (2007)



Semantic Scholar Logo Some data provided by SemanticScholar